Health Catalyst, Inc. (HCAT)
USD 3.89
(-1.27%)
USD 3.89
(-1.27%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 258.73 Million USD | -34.71% |
| 2022 | 273.19 Million USD | 4.58% |
| 2021 | 261.22 Million USD | 39.77% |
| 2020 | 186.89 Million USD | 38.99% |
| 2019 | 134.46 Million USD | 19.19% |
| 2018 | 112.81 Million USD | 50.46% |
| 2017 | 74.97 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 37.5 Million USD | -13.54% |
| 2024 Q1 | 43.38 Million USD | -0.74% |
| 2023 Q2 | 68.39 Million USD | -2.96% |
| 2023 FY | 178.36 Million USD | -34.71% |
| 2023 Q4 | 43.7 Million USD | -22.73% |
| 2023 Q3 | 56.56 Million USD | -17.29% |
| 2023 Q1 | 70.47 Million USD | 3.95% |
| 2022 Q3 | 77.73 Million USD | 12.3% |
| 2022 FY | 273.19 Million USD | 4.58% |
| 2022 Q2 | 69.21 Million USD | 18.45% |
| 2022 Q1 | 58.43 Million USD | -22.71% |
| 2022 Q4 | 67.8 Million USD | -12.78% |
| 2021 FY | 261.22 Million USD | 39.77% |
| 2021 Q2 | 61.89 Million USD | 17.17% |
| 2021 Q1 | 52.82 Million USD | -19.56% |
| 2021 Q3 | 70.9 Million USD | 14.55% |
| 2021 Q4 | 75.6 Million USD | 6.63% |
| 2020 FY | 186.89 Million USD | 38.99% |
| 2020 Q4 | 65.67 Million USD | 41.85% |
| 2020 Q3 | 46.29 Million USD | 29.43% |
| 2020 Q2 | 35.77 Million USD | -8.64% |
| 2020 Q1 | 39.15 Million USD | 10.3% |
| 2019 Q1 | 28.98 Million USD | -4.32% |
| 2019 FY | 134.46 Million USD | 19.19% |
| 2019 Q4 | 35.49 Million USD | -14.52% |
| 2019 Q3 | 41.52 Million USD | 45.93% |
| 2019 Q2 | 28.45 Million USD | -1.81% |
| 2018 Q4 | 30.29 Million USD | -6.41% |
| 2018 Q1 | 20.87 Million USD | 0.0% |
| 2018 Q2 | 29.28 Million USD | 40.26% |
| 2018 Q3 | 32.36 Million USD | 10.53% |
| 2018 FY | 112.81 Million USD | 50.46% |
| 2017 FY | 74.97 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accolade, Inc. | 306.51 Million USD | 15.589% |
| Aclarion, Inc. | 4.87 Million USD | -5206.567% |
| Aclarion, Inc. | 4.87 Million USD | -5206.567% |
| Augmedix, Inc. | 40.3 Million USD | -541.93% |
| HeartBeam, Inc. | 15.31 Million USD | -1589.5% |
| HeartBeam, Inc. | 15.31 Million USD | -1589.5% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -4667.174% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 79.891% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 79.891% |
| CareCloud, Inc. | 93.35 Million USD | -177.14% |
| CareCloud, Inc. | 93.35 Million USD | -177.14% |
| Certara, Inc. | 254.08 Million USD | -1.827% |
| CareMax, Inc. | 670.05 Million USD | 61.387% |
| Definitive Healthcare Corp. | 546.47 Million USD | 52.655% |
| EUDA Health Holdings Limited | 4.8 Million USD | -5286.697% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 95.285% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -1327.476% |
| MSP Recovery, Inc. | 565.43 Million USD | 54.242% |
| Mangoceuticals, Inc. | 9.65 Million USD | -2581.031% |
| National Research Corporation | 52.52 Million USD | -392.631% |
| Nutex Health, Inc. | 66.54 Million USD | -288.788% |
| OptimizeRx Corporation | 69.3 Million USD | -273.339% |
| R1 RCM Inc. | 336.6 Million USD | 23.134% |
| Renalytix Plc | 29.04 Million USD | -790.913% |
| Sharecare, Inc. | 225.97 Million USD | -14.495% |
| Sharecare, Inc. | 225.97 Million USD | -14.495% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -655.041% |
| Spok Holdings, Inc. | 90.97 Million USD | -184.384% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -729.529% |
| TruBridge, Inc. | 206.17 Million USD | -25.493% |
| 10x Genomics, Inc. | 674.94 Million USD | 61.667% |
| Zhongchao Inc. | 13.92 Million USD | -1758.362% |